Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ANAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ANAB

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

AnaptysBio Inc

ANAB
Current price
26.86 USD +0.05 USD (+0.19%)
Last closed 26.63 USD
ISIN US0327241065
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 789 160 256 USD
Yield for 12 month -22.03 %
1Y
3Y
5Y
10Y
15Y
ANAB
21.11.2021 - 28.11.2021

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California. Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

42.55 USD

P/E Ratio

Dividend Yield

Financials ANAB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ANAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+91 280 000 USD

Last Year

+17 157 000 USD

Current Quarter

+27 771 000 USD

Last Quarter

+43 113 000 USD

Current Year

+88 883 000 USD

Last Year

+14 781 000 USD

Current Quarter

+27 771 000 USD

Last Quarter

+43 113 000 USD
EBITDA -99 698 000 USD
Operating Margin TTM -99.17 %
Price to Earnings
Return On Assets TTM -15.14 %
PEG Ratio
Return On Equity TTM -343.83 %
Wall Street Target Price 42.55 USD
Revenue TTM 111 872 000 USD
Book Value 1.12 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 286.80 %
Dividend Yield
Gross Profit TTM -56 106 000 USD
Earnings per share -4.76 USD
Diluted Eps TTM -4.76 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -125.70 %

Stock Valuation ANAB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.18
Price Sales TTM 7.05
Enterprise Value EBITDA -1.30
Price Book MRQ 23.27

Technical Indicators ANAB

For 52 Weeks

12.21 USD 41.31 USD
50 Day MA 22.32 USD
Shares Short Prior Month 9 153 626
200 Day MA 21.19 USD
Short Ratio 12.72
Shares Short 9 362 857
Short Percent 56.23 %